Literature DB >> 15266348

M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia.

Brian Dean.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15266348     DOI： 10.1038/sj.npp.1300508

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  3 in total

1.  Discovery of potential antipsychotic agents possessing pro-cognitive properties.

Authors:  Jelveh Lameh; Krista McFarland; Jorgen Ohlsson; Fredrik Ek; Fabrice Piu; Ethan S Burstein; Ali Tabatabaei; Roger Olsson; Stefania Risso Bradley; Douglas W Bonhaus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-15       Impact factor: 3.000

2.  Layer 2/3 synapses in monocular and binocular regions of tree shrew visual cortex express mAChR-dependent long-term depression and long-term potentiation.

Authors:  Portia McCoy; Thomas T Norton; Lori L McMahon
Journal:  J Neurophysiol       Date:  2008-05-14       Impact factor: 2.714

Review 3.  The importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experience.

Authors:  Irina Dedova; Antony Harding; Donna Sheedy; Therese Garrick; Nina Sundqvist; Clare Hunt; Juliette Gillies; Clive G Harper
Journal:  Int J Mol Sci       Date:  2009-01-23       Impact factor: 6.208
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.